InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Protopapas Anna, 董事长兼首席执行官. Director active across 4 companies, notably Dicerna Pharmaceuticals Inc. Aggregated, 16 disclosures have been recorded. Activity tracked since 20 May 2022. The latest transaction was filed on 15 July 2026 (U). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Protopapas Anna
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
3,444 股Class A Common Stock - Restricted Stock UnitsSEC:0001193125-26-305052:1
5,146 股@ US$124.000.0065% mcap92.9% 占其流量Class A Common StockSEC:0001193125-26-305052:0
6,721 股Common StockSEC:0001104659-26-001374:0
2,647 股0Class A Common StockSEC:0000950170-25-088549:0
21,250 股0Common StockSEC:0001104659-25-004596:0
16,750 股0Common StockSEC:0001104659-25-004187:0
31,250 股0Common StockSEC:0001104659-25-003881:0
2,499 股0Class A Common StockSEC:0000950170-24-073656:0
31,250 股0Common StockSEC:0001104659-24-004551:0
5,000 股@ US$9.36100.0% 占其流量Class A Common StockSEC:0001209191-23-059368:0
16,643 股0Common StockSEC:0001104659-23-100443:0
240,244 股0Common StockSEC:0001104659-23-004744:0
38,958 股Common StockSEC:0001104659-22-005548:0
100,000 股Common StockSEC:0001104659-21-093665:0
3,333 股Common StockSEC:0001399529-21-000107:0
23,902 股Common StockSEC:0001127602-16-039337:0
16 条申报中的 16 条
About Protopapas Anna
Protopapas Anna is Président-Directeur Général. She has 16 filings in total. In the 16 recent filings we hold, the period runs from 2016-02-03 to 2026-07-15, with the most frequent transaction nature listed as Levée d'options. The companies mentioned are Mersana Therapeutics, Inc., Nuvalent, Inc., Dicerna Pharmaceuticals Inc and ARIAD PHARMACEUTICALS INC.
